4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/6BIO/AG-MR-C0019-M010/10 mg
商品详细Adipogen/6BIO/AG-MR-C0019-M010/10 mg
Adipogen/6BIO/AG-MR-C0019-M010/10 mg
Adipogen/6BIO/AG-MR-C0019-M010/10 mg
商品编号: AG-MR-C0019-M010
品牌: Adipogen Inc
市场价: ¥2400.00
美元价: 1440.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsBIO;6-Bromoindirubin-3"-oxime
ProductTypeChemical
Properties
FormulaC16H10BrN3O2
MW356.2
CAS667463-62-9
PurityChemicals≥99%(NMR)
AppearanceDarkredsolid.
SolubilitySolubleinDMSOorethanol.
ReconstitutionStocksolutionscanbemadeupto10mMinDMSO.
IdentityDeterminedby1H-NMR.
InChiKeyDDLZLOKCJHBUHD-WAVHTBQISA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepcoolanddry.
Protectfromlight.
Protectfromlightandmoisture.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Potent,reversIBLeandATP-competitiveglycogensynthasekinase-3α/β(GSK-3α/β)inhibitor.
  • JAK/STAT3signalinginhibitor.
  • Phosphoinositide-dependentkinase1(PDK1)inhibitor.
  • Anticancercompound.
  • Potentantiproliferativeagent.Suppressesmetastasis.
  • Apoptosisinducer.
  • Sustainspluripotencyandself-renewalofhumanandmouseembryonicstemcells(ESCs)byactivationoftheWntsignalingpathway.
  • Anti-leishmanial(IC50=0.150μM).
  • Proto-oncogenetyrosine-proteinkinasereceptorRETinhibitor(IC50=0.51μM).
  • InhibitsHIV-1transcriptionandprotectsagainstTatinducedneurotoxicity.
ProductReferences
  1. GSK-3-selectiveinhibitorsderivedfromTyrianpurpleindirubins:L.Meijer,etal.;Chem.Biol.10,1255(2003)
  2. Structuralbasisforthesynthesisofindirubinsaspotentandselectiveinhibitorsofglycogensynthasekinase-3andcyclin-dependentkinases:P.Polychronopoulos,etal.;J.Med.Chem.47,935(2004)
  3. MaintenanceofpluripotencyinhumanandmouseembryonicstemcellsthroughactivationofWntsignalingbyapharmacologicalGSK-3-specificinhibitor:N.Sato,etal.;Nat.Med.10,55(2004)
  4. TheGSK-3inhibitorBIOpromotesproliferationinmammaliancardiomyocytes:A.S.Tseng,etal.;Chem.Biol.13,957(2006)
  5. 7-Bromoindirubin-3"-oximeinducescaspase-independentcelldeath:J.Ribas,etal.;Oncogene25,6304(2006)
  6. Indirubin,theredshadeofindigo:L.Meijer,etal.(Editors):In«LifeinProgress»,StationBIOLOGique,Roscoff,297pp.(2006)
  7. Indirubinderivativesinhibitmalignantlymphoidcellproliferation:A.Chebel,etal.;Leuk.Lymphoma50,2049(2009)
  8. 6-Br-5methylindirubin-3"oxime(5-Me-6-BIO)targetingtheleishmanialglycogensynthasekinase-3(GSK-3)shortformaffectscell-cycleprogressionandinducesapoptosis-likedeath:ExploitationofGSK-3fortreatingleishmaniasis:E.Xingi,etal.;Int.J.Parasit.39,1289(2009)
  9. Anticancereffectsandantimetastaticmechanismsofnovelindirubinderivatives:C.A.Kressirer;Diss.Ludwig-Maximilians-UniversitaetMunchen,(2010)
  10. 6-Bromoindirubin-3"-OximeInhibitsJAK/STAT3SignalingandInducesApoptosisofHumanMelanomaCells:L.Liu,etal.;CancerRes.71,3972(2011)
  11. InhibitionofTat-mediatedHIV-1replicationandneurotoxicitybynovelGSK3-betainhibitors:K.Kehn-Hall,etal.;Virology415,56(2011)
  12. Inductionofdiscreteapoptoticpathwaysbybromo-substitutedindirubinderivativesininvasivebreastcancercells:K.A.Nicolaou,etal.;BBRC425,76(2012)
  13. FromTyrianpurpletokinasemodulators:naturallyhalogenatedindirubinsandsyntheticanalogues:K.Vougogiannopoulou&A.L.Skaltsounis;PlantaMed.78,1518(2012)
  14. Pleiotrophinsuppressionofreceptorproteintyrosinephosphatase-β/ζmaintainstheself-renewalcompetenceoffetalhumanoligodendrocyteProgenitorcells:C.R.McClain,etal.;J.Neurosci.32,15066(2012)
  15. NovelinversebindingmodeofindirubinderivativesyieldsimprovedselectivityforDYRKkinases:V.Myrianthopoulos,etal.;ACSMed.Chem.Lett4,22(2013)
  16. IndirubinDerivative6BIOSuppressesMetastasis:S.Braig,etal.;CancerRes.73,6004(2013)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。